Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 24/08/26

Trade details

Type
Insider sale
Amount
$802,926.14
Shares · price
2,306 sh · $348.19 a share
Held after
801 sh
Trade date
24/08/23
Filed
24/08/26
Days to filing
3 days

Sold 74.2% of holdings

Share of holding sold
74.2%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/24~24/09/22

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $220.2K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $218.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $153.5K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $131.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $114.8K

    Filed 10/01

Martine A. Rothblatt, Chairman — sold $802.9K of United Therapeutics UTHR · 74.2% of holdings · 10b5-1 plan | Whalegun